http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2851425-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1b422628afc08c137e03c2ccbbcf22d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 2011-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3daef7ef7089b31e22835b10f3f3efdf
publicationDate 2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2851425-A1
titleOfInvention Anti-tumoral compound and relative production process
abstract The present invention relates to an anti-tumoral compound for the localized treatment of neoplastic pathologies of malignant kind that cannot be surgically removed or with a high risk of local recurrence, comprising: a bicomponent injectable biologic glue; an antineoplastic substance; an epinephrine-based solution. Said compound may be used as an independent therapeutic treatment, as it allows to treat tumoral masses that are not surgically removable, or as a therapeutic treatment complementary to surgical removal or to known ablative techniques (laser, radiofrequency, microwaves, etc.) for a maximization of the efficiency of said therapies reducing the risk of neoplastic relapses in the original surgical site. A process for the production of said antitumor compound is also object of the present invention.
priorityDate 2011-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452546156
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453213080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937

Total number of triples: 45.